BioLife4D Corp Contracts & Agreements
72 Contracts & Agreements
- Business Finance (41 contracts)
- Business Operations (15)
- Human Resources (3)
- Intellectual Property (4)
- Uncategorized (9)
- Second Amendment to Amended and Restated Secured Promissory Note among the BioLife4D SM Trust, Gary Reynolds, and BioLife4D Corporation, dated June 12, 2023 (Filed With SEC on June 13, 2023)
- First Amendment to Agreement by and between BioLife4D Corporation and Fifth Third Bank, National Association, dated June 7, 2023 (Filed With SEC on June 13, 2023)
- Promissory Note between BioLife4D Corporation and Steven Morris, dated June 8, 2023 (Filed With SEC on June 13, 2023)
- Form of Underwriting Agreement between BioLife4D Corporation and Aegis Capital Corp (Filed With SEC on April 20, 2023)
- Form of Underwriters Warrant (Filed With SEC on April 20, 2023)
- Form of Warrant (Filed With SEC on April 20, 2023)
- Promissory Note dated April 5, 2023 by BioLife4D Corporation for 1030 Trust (Filed With SEC on April 20, 2023)
- Business Loan Agreement, dated December 6, 2022, by and between BioLife4D Corporation and Fifth Third Bank, National Association (Filed With SEC on December 19, 2022)
- Promissory Note, dated May 18, 2022, made by BioLife4D Corporation in favor of Fifth Third Bank, National Associate (Filed With SEC on December 19, 2022)
- Assignment of Deposit Account, dated December 6, 2022, by and among BioLife4D SM Trust dated December 6, 2022, by and among BioLife4D SM Trust dated November 1, 2016, BioLife4D... (Filed With SEC on December 19, 2022)
- Amended and Restated Secured Promissory Note, dated December 7, 2022, by the BioLife4D SM Trust, dated November 1, 2016 (Filed With SEC on December 19, 2022)
- Amended and Restated Stock Pledge Agreement, dated December 7, 2022, by the BioLife4D SM Trust, dated November 1, 2016 (Filed With SEC on December 19, 2022)
- Agreement, dated December 6, 2022, between BioLife4D Corporation and BioLife4D SM Trust, dated November 1, 2016 (Filed With SEC on December 19, 2022)
- Form of Underwriting Agreement between BioLife4D Corporation and Aegis Capital Corp (Filed With SEC on November 15, 2022)
- Form of Underwriting Agreement between BioLife4D Corporation and Aegis Capital Corp (Filed With SEC on September 21, 2022)
- Form of Warrant (Filed With SEC on September 21, 2022)
- Form of Underwriting Agreement between BioLife4D Corporation and Aegis Capital Corp (Filed With SEC on September 8, 2022)
- Form of Underwriters Warrant (Filed With SEC on September 8, 2022)
- Form of Warrant Agent Agreement (Filed With SEC on September 8, 2022)
- Form of Warrant (Filed With SEC on September 8, 2022)
- Form of Warrant Agent Agreement for Pre-funded Warrants (Filed With SEC on September 8, 2022)
- Form of Pre-Funded Warrant (Filed With SEC on September 8, 2022)
- Form of Additional Warrant (Filed With SEC on September 8, 2022)
- Amendment to CFO Agreement between BioLife4D Corporation and Wesley Ramjeet, dated August 11, 2022 (Filed With SEC on September 8, 2022)
- Executive Employment Agreement between BioLife4D Corporation and Steven Morris, dated September 2, 2022 (Filed With SEC on September 8, 2022)
- Option Agreement between BioLife4D Corporation and Dr. Jeffrey Morgan, dated January 26, 2022, effective as of August 1, 2020 (Filed With SEC on September 8, 2022)
- Option Agreement between BioLife4D Corporation and Dr. Jeffrey Morgan, dated January 26, 2022, effective as of August 6, 2021 (Filed With SEC on September 8, 2022)
- Amendment to Advisory Board Agreement between BioLife4D Corporation and Ibrahim T. Ozbolat, dated January 14, 2022 (Filed With SEC on July 21, 2022)
- CFO Agreement between BioLife4D Corporation and Wesley Ramjeet, dated February 1, 2022 (Filed With SEC on July 21, 2022)
- Form of Warrant Agent Agreement (Filed With SEC on June 3, 2022)
- Advisory Board Agreement between BioLife4D Corporation and Sean Palecek, dated May 30, 2017 (Filed With SEC on June 3, 2022)
- Amendment to Advisory Board Agreement between BioLife4D Corporation and Sean Palecek, dated January 17, 2022 (Filed With SEC on June 3, 2022)
- Advisory Board Agreement between BioLife4D Corporation and Ibrahim T. Ozbolat, dated May 31, 2017 (Filed With SEC on June 3, 2022)
- Amendment to Advisory Board Agreement between BioLife4D Corporation and Ibrahim T. Ozbolat, dated January 14, 2022 (Filed With SEC on June 3, 2022)
- Advisory Board Agreement between BioLife4D Corporation and Janet Zoldan, dated June 8, 2017 (Filed With SEC on June 3, 2022)
- Amendment to Advisory Board Agreement between BioLife4D Corporation and Janet Zoldan, dated February 1, 2022 (Filed With SEC on June 3, 2022)
- Advisory Board Agreement between BioLife4D Corporation and Shayn Peirce-Cottler, dated July 11, 2017 (Filed With SEC on June 3, 2022)
- Amendment to Advisory Board Agreement between BioLife4D Corporation and Shayn Peirce-Cottler, dated February 1, 2022 (Filed With SEC on June 3, 2022)
- Advisory Board Agreement between BioLife4D Corporation and Jeffrey Morgan, dated August 23, 2017 (Filed With SEC on June 3, 2022)
- Amendment to Advisory Board Agreement between BioLife4D Corporation and Jeffrey Morgan, dated February 1, 2022 (Filed With SEC on June 3, 2022)
- Advisory Board Agreement between BioLife4D Corporation and Raimond Winslow, dated August 28, 2017 (Filed With SEC on June 3, 2022)
- Laboratory Service Agreement between BioLife4D Corporation and Northwestern University, dated November 1, 2017 (Filed With SEC on June 3, 2022)
- License Agreement between BioLife4D Corporation and Texas Medical Center, dated May 24, 2018 (Filed With SEC on June 3, 2022)
- First Amendment to License Agreement between BioLife4D Corporation and Texas Medical Center, dated July 3, 2018 (Filed With SEC on June 3, 2022)
- Second Amendment to License Agreement between BioLife4D Corporation and Texas Medical Center, dated October 29, 2018 (Filed With SEC on June 3, 2022)
- Third Amendment to License Agreement between and BioLife4D Corporation and Texas Medical Center, dated February 7, 2022 (Filed With SEC on June 3, 2022)
- Note Purchase Agreement between BioLife4D Corporation and EchoVenture, LLC, dated January 3, 2019 (Filed With SEC on June 3, 2022)
- Extension to the Note Purchase Agreement between BioLife4D Corporation and EchoVenture, LLC, dated January 12, 2022 (Filed With SEC on June 3, 2022)
- Advisory Board Agreement between BioLife4D Corporation and Stephen M. Simes, dated January 21, 2019 (Filed With SEC on June 3, 2022)
- Note Purchase Agreement between BioLife4D Corporation and H Joseph Leitch, dated January 22, 2019 (Filed With SEC on June 3, 2022)
- Extension to the Note Purchase Agreement between BioLife4D Corporation and H Joseph Leitch, dated January 13, 2022 (Filed With SEC on June 3, 2022)
- Note Purchase Agreement between BioLife4D Corporation and 2 JWB 6P LLC, dated January 28, 2019 (Filed With SEC on June 3, 2022)
- Extension to the Note Purchase Agreement between BioLife4D Corporation and 2 JWB 6P LLC, dated January 12, 2022 (Filed With SEC on June 3, 2022)
- Note Purchase Agreement between BioLife4D Corporation and Millennium Automated Parking, Inc. and Julius S. Levine Trust, dated January 31, 2019 (Filed With SEC on June 3, 2022)
- Extension to the Note Purchase Agreement between BioLife4D Corporation and Millennium Automated Parking, Inc., dated January 12, 2022 (Filed With SEC on June 3, 2022)
- Extension to the Note Purchase Agreement between BioLife4D Corporation and Julius S. Levine Trust, dated January 12, 2022 (Filed With SEC on June 3, 2022)
- Note Purchase Agreement between BioLife4D Corporation and Clayton A. Struve, dated January 31, 2019 (Filed With SEC on June 3, 2022)
- Extension to the Note Purchase Agreement between BioLife4D Corporation and Clayton A. Struve, dated January 13, 2022 (Filed With SEC on June 3, 2022)
- Employment Agreement between BioLife4D Corporation and Kathleen Ann Lewis, dated September 15, 2020 (Filed With SEC on June 3, 2022)
- Engagement Letter between BioLife4D Corporation and The Hechtman Group LTD, dated July 22, 2021 (Filed With SEC on June 3, 2022)
- Intelligent Office Membership Agreement between BioLife4D Corporation and Aspire Ventures, LLC d/b/a Intelligent Office of Lincolnshire, dated December 29, 2021 (Filed With SEC on June 3, 2022)
- Platform-as-a-Service Monthly Service Agreement between BioLife4D Corporation and Advanced Solutions Life Sciences, LLC, dated December 20, 2021 (Filed With SEC on June 3, 2022)
- Independent Advisor Agreement between BioLife4D Corporation and Ravi Birla, dated January 11, 2022 (Filed With SEC on June 3, 2022)
- CFO Agreement between BioLife4D Corporation and Wesley Ramjeet, dated February 1, 2022 (Filed With SEC on June 3, 2022)
- 2022 Incentive and Nonstatutory Stock Option Plan to Employees, Directors, and Consultants of BioLife4D Corporation, dated February 3, 2022 (Filed With SEC on June 3, 2022)
- 2022 Restricted Stock Plan, dated February 3, 2022 (Filed With SEC on June 3, 2022)
- Business Loan Agreement, dated May 18, 2022, by and between BioLife4D Corporation and Fifth Third Bank, National Association (Filed With SEC on June 3, 2022)
- Promissory Note, dated May 18, 2022, made by BioLife4D Corporation in favor of Fifth Third Bank, National Association (Filed With SEC on June 3, 2022)
- Assignment of Deposit Account, dated May 18, 2022, by and among BioLife4D SM Trust dated November 1, 2016, BioLife4D Corporation and Fifth Third Bank, National Association (Filed With SEC on June 3, 2022)
- Secured Promissory Note, dated May 18, 2022, made by BioLife4D SM Trust, dated November 1, 2016 (Filed With SEC on June 3, 2022)
- Stock Pledge Agreement, dated May 18, 2022, by the BioLife4D SM Trust, dated November 1, 2016 (Filed With SEC on June 3, 2022)
- Agreement, dated May 18, 2022, between BioLife4D Corporation and BioLife4d SM Trust, dated November 1, 2016 (Filed With SEC on June 3, 2022)